Xiao-Jing Wang was named chief science officer at UC Davis Comprehensive Cancer Center.
The National Comprehensive Cancer Network announced the recipients of its 2022 awards.
Abdul Rafeh Naqash, a medical oncologist and phase I clinical trialist at the University of Oklahoma Health Stephenson Cancer Center, was granted an Impact Award from SWOG Cancer Research Network’s Hope Foundation for Cancer Research.
Stand Up To Cancer established two teams, the SU2C Lung Cancer Health Equity Research Team and SU2C Catalyst, that aim to improve cancer health equity.
Researchers from the SWOG Cancer Research Network used methylation patterns in cell-free DNA extracted from blood samples to predict which patients with muscle-invasive bladder cancer were likely to benefit from chemotherapy before their surgery.
Researchers from Roswell Park Comprehensive Cancer Center uncovered a previously unknown function of a gene that regulates the p53 protein, mutations of which have been linked to a wide variety of cancers.
Researchers with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute found that vascular endothelial growth factor-A (VEGF-A)—a potent cytokine—can increase expression of dopamine D2 receptors on endothelial cells.
Scientists at Yale Cancer Center found that patients with breast cancer and high levels of insulin in the blood may be responsive to metabolism-targeting treatments, which in turn may improve the effectiveness of subsequent chemotherapy treatments.
Using single-cell analysis, researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center found that previously identified subtypes for colorectal cancer may not offer nuanced tumor classification.
Research from Cedars-Sinai Cancer showed that a combination of androgen deprivation therapy plus pelvic lymph node radiation kept nearly 90% of clinical trial patients’ prostate cancer at bay for five years.
